Is Oryzon Genomics S.A. (ORY.MC) a Buy, Sell, or Hold?
BME : ORY.MC
Oryzon Genomics S.A. — Competitors
$2.912 EUR
$0.0 (-0.14%)
- Volume
- 97.66K
- Average Volume
- 457.24K
- Market Capitalization
- $238.66M
- P/E Ratio
- -93.33
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.02
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.60
ORY.MC vs. The Competition
| Properties | ORY.MC | ATRY.MC | BST.MC | CBAV.MC |
|---|---|---|---|---|
| Market Cap | $238.66M | $195.11M | $16.72M | $977.64M |
| Shares Outstanding | $81.96M | $75.92M | $74.96M | $16.03M |
| P/E Ratio | -93.33 | -1.94 | -8.2 | 21.86 |
| EPS | -0.03 | -1.32 | -0.03 | 2.89 |
| Day Low | 2.9 | 2.555 | 0.223 | 61 |
| Day High | 2.946 | 2.6 | 0.225 | 61.6 |
| Year Low | 2.555 | 2.31 | 0.176 | 40.1 |
| Year High | 4.02 | 3.59 | 0.475 | 61.8 |
| Average Price 50 | 3.01992 | 2.5964 | 0.23094 | 57.312 |
| Average Price 200 | 3.03959 | 2.82333 | 0.24292 | 51.342 |
| Volume | 97661 | 6594 | 90208 | 174 |
| Average Volume | - | - | - | - |